Skip to main content

Table 3 10-year Monte-Carlo simulation outcomes

From: Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France

Monte-Carlo simulations (N = 30,000)

No-treatment

Real-world persistence

Ideal persistence

Clinical fractures

Vertebrae

8,193

6,308

3,912

 

Hip

5,534

4,462

3,313

 

Wrist

6,674

5,941

5,153

 

Total

20,401

16,711

12,378

Fractured women

(proportion)

20,131

(67,1%)

17,996

(60.0%)

14,715

(49.1%)

Deaths

(proportion)

1,816

(6.1%)

1,466

(4.9%)

1,015

(3.4%)